NCT04129866

Brief Summary

The Mobile-Interpretation Bias Modification clinical trial aims to examine the efficacy of a brief mobile phone delivered interpretation bias modification to reduce anxiety sensitivity cognitive concerns and suicidal ideation in National Guard Personnel. The investigators propose a randomized controlled trial testing the efficacy, acceptability, and usability of M-IBM with a sample of 114 National Guardsmen with current suicidal ideation and elevated anxiety sensitivity cognitive concerns. Participants will complete assessments, receive assistance on installing M- IBM on their phone, complete an M-IBM intervention session, and complete post-intervention assessments. Baseline measures of psychopathology, and usability/acceptability of M-IBM will be obtained during the initial session. In addition, 1-month, and 3-month follow-ups would be scheduled to examine changes in psychopathology. The investigators hypothesize that those randomized to M-IBM will experience reductions in anxiety sensitivity cognitive concerns, suicidal ideation. In addition participants will find M-IBM acceptable and easy to use.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
114

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 10, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 17, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

December 15, 2019

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 29, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 29, 2023

Completed
Last Updated

May 27, 2022

Status Verified

May 1, 2022

Enrollment Period

3.3 years

First QC Date

October 10, 2019

Last Update Submit

May 26, 2022

Conditions

Outcome Measures

Primary Outcomes (5)

  • Anxiety Sensitivity Index-3 Cognitive Concerns Subscale

    Range 0 - 24, Higher Scores mean more pathology

    30 minutes

  • Anxiety Sensitivity Index-3 Cognitive Concerns Subscale

    Range 0 - 24, Higher Scores mean more pathology

    1 month post intervention

  • Anxiety Sensitivity Index-3 Cognitive Concerns Subscale

    Range 0 - 24, Higher Scores mean more pathology

    3 months post intervention

  • The Self-Injurious Thoughts and Behaviors Interview

    1 month post intervention

  • The Self-Injurious Thoughts and Behaviors Interview

    3 months post intervention

Study Arms (2)

M-IBM

EXPERIMENTAL

M-IBM is based on a slightly modified version of the word sentence association paradigm focused on words and sentences related to common concerns among those with elevated anxiety sensitivity cognitive concerns (i.e., losing control of mental processes).

Behavioral: M-IBM

Control IBM

PLACEBO COMPARATOR

Control-IBM is identical to M-IBM except that the sentence that follows the cue word is not related to an anxious-threat interpretation of the cue word.

Behavioral: Control-IBM

Interventions

M-IBMBEHAVIORAL

In this paradigm, an ambiguous word or two-word phrase related to ASCC is followed by a sentence that resolves the word-sentence meaning as threatening or benign. For example, participants are presented with an ambiguous word or two-word phrase for 1 second. On half the trials the combination of the word/phrase and sentence creates a benign meaning (as in the previous example). On the other half of trials this combination creates an anxious-threat meaning Participants are required to judge the relatedness of the word/phrase and the sentence. Participants are given feedback during training such that judging the anxious-threat combinations to be "unrelated" and the benign combinations as being "related" would produce a "correct" response. In contrast, if participants produce an "incorrect" response they see "incorrect".

M-IBM
Control-IBMBEHAVIORAL

Placebo IBM where sentences are not related to anxious threat meaning of cue word.

Control IBM

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Elevated ASCC (\>2) and include only Guard members who also have current SI (\> 0) .
  • Ownership of a smartphone

You may not qualify if:

  • those determined by military or study personnel to be actively psychotic, manic, or imminently suicidal and in need of emergency services

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Southern Mississippi

Hattiesburg, Mississippi, 39406-0002, United States

Location

MeSH Terms

Conditions

Suicidal Ideation

Condition Hierarchy (Ancestors)

SuicideSelf-Injurious BehaviorBehavioral SymptomsBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 10, 2019

First Posted

October 17, 2019

Study Start

December 15, 2019

Primary Completion

March 29, 2023

Study Completion

March 29, 2023

Last Updated

May 27, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations